Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant

Natalizumab is used as a second-line treatment for multiple sclerosis (MS). Some reports have linked natalizumab to primary central nervous system lymphoma (PCNSL), although few have described its management. A 45-year-old woman with Balo’s Concentric Sclerosis presented dizziness, vertigo accompani...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Karine Moineau-Vallée, Justine Rinfret, My Hanh Luu Hoai, Valérie St-Louis, France Berthelet, Laurent Létourneau-Guillon, Émilie Lemieux-Blanchard, Alexandre Prat, Jean-Philippe Adam
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2020-12-01
Saila:	Current Oncology
Gaiak:	multiple sclerosis primary central nervous system lymphoma natalizumab autologous hematopoietic stem cell transplant
Sarrera elektronikoa:	https://www.mdpi.com/1718-7729/28/1/22
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!